Fundamental studies with cisplatin.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002273:Carcinogens; D055598:Chemical Phenomena; D002621:Chemistry; D002945:Cisplatin / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D046508:Culture Techniques; D004247:DNA / Q000378:metabolism; D004285:Dogs; D004334:Drug Administration Schedule; D004351:Drug Resistance; D006801:Humans; D007536:Isomerism; D051379:Mice; D009153:Mutagens; D009369:Neoplasms / Q000188:drug therapy*; D051381:Rats; D014018:Tissue Distribution
D002273:Carcinogens; D009153:Mutagens; D004247:DNA; D002945:Cisplatin